Aradigm Corporation Stock OTC Bulletin Board
Equities
ARDM
US0385053014
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2020 | Aradigm Corporation Went Out of Business | CI |
2020 | Modified Combined Liquidation Plan and Discosure Statement Approved for Aradigm Corporation | CI |
Financials (USD)
Sales 2016 | 195K | Sales 2017 | 14.46M | Capitalization | 97.3M |
---|---|---|---|---|---|
Net income 2016 | -32M | Net income 2017 | -10M | EV / Sales 2016 | 73.3 x |
Net cash position 2016 | 9.37M | Net Debt 2017 | 7.91M | EV / Sales 2017 | 7.27 x |
P/E ratio 2016 |
-0.72
x | P/E ratio 2017 |
-9.3
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 60.28% |
1st Jan change | Capi. | |
---|---|---|
+19.41% | 45.51B | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- ARDMQ Stock
- ARDM Stock